Drug Interaction Report

Acarbose and Carvedilol: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 10, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Acarbose

Prandase® Precose Precose®
+

Carvedilol

Coreg Coreg® Coreg® CR
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 10, 2026
LinkedIn
Interaction severity
Moderate
Can be significant — usually manageable with monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 135 documented Acarbose interactions, 64 are rated moderate — including this one.
At a glance Some uncertainty
The Bottom Line
Carvedilol can shift your blood sugar and hide the fast-heartbeat warning of a low, so monitor more closely and know the other low-sugar signs; your team can adjust doses as needed.

Acarbose helps control your blood sugar, and carvedilol is a beta-blocker used for the heart and blood pressure. When taken together, two things can happen. First, the beta-blocker can change how your body handles blood sugar, so your levels may swing a little higher or lower. Second, and more importantly, carvedilol can hide the usual warning signs of low blood sugar, like a racing heartbeat. You might still feel sweaty or shaky, but the fast heartbeat that tips people off may be muted.

The good news is your care team can manage this easily by checking your blood sugar a bit more often and adjusting doses if needed. Keep taking both as prescribed and let them know how you feel.

Effect: Beta-blockade with carvedilol may alter glycemic control (hypo- or hyperglycemia) and blunt adrenergic warning signs of hypoglycemia, notably tachycardia; sweating and dizziness are generally preserved. Neither drug is a prodrug requiring activation here; this is largely a pharmacodynamic interaction.

  • Direction: variable glucose effect; masking of hypoglycemia symptoms.
  • Onset: delayed. Evidence: probable. Severity: moderate.
  • Note: carvedilol is nonselective and may potentiate hypoglycemia and delay glucose recovery; heart failure patients with diabetes may see worsening hyperglycemia.

Management: Increase frequency of glucose monitoring; individualize antidiabetic dosing. Counsel on non-cardiac hypoglycemia cues. If carvedilol is withdrawn, watch for loss of glycemic control.

Onset
delayed
Evidence
probable
Severity
Moderate

What happens

Hypoglycemia or hyperglycemia; decreased symptoms of hypoglycemia

Interaction Deep Dive

When antidiabetic medications are taken together with beta-blockers, the result may be either hypoglycemia or hyperglycemia, and hypoglycemic symptoms may also be masked12. The effect can reach tachycardia, though it does not extend to other hypoglycemic manifestations such as dizziness and sweating6. The hypoglycemia produced by insulin can be intensified by nonselective beta-blockers, which may also hinder the return of serum glucose to normal levels. In individuals who have both heart failure and diabetes, hyperglycemia may worsen7. It may become necessary to monitor glucose more often or to adjust the dose of the antidiabetic agent12. During combined therapy, watch carefully for signs and symptoms of hypoglycemia, and should the beta-blocker be discontinued, monitor for a loss of glycemic control3.

Why it happens (mechanism)

Altered glucose metabolism and beta blockade

How to manage this interaction

This combination is commonly used and manageable. The main points:

  • Keep taking both acarbose and carvedilol as prescribed unless your prescriber tells you otherwise.
  • Your team may check your blood sugar more often, especially when starting or changing either drug.
  • Your antidiabetic dose may need to be adjusted and individualized by your care team.
  • Learn the non-heartbeat signs of low blood sugar (sweating, shakiness, confusion), since the racing-heartbeat warning may be blunted.
  • If your carvedilol is ever stopped, tell your team so they can watch for rising blood sugar.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

2 reports — tap to read

a) In elderly diabetic patients receiving either insulin or sulfonylureas, the selection of antihypertensive agent had minimal impact on the risk of hypoglycemia; however, once other risk factors were taken into account, the lowest risk was seen with cardioselective beta blockers and the highest with non-cardioselective beta blockers, while other antihypertensive drugs produced intermediate outcomes (N=13,559) 4.

b) In patients with hypertension and non-insulin dependent diabetes, beta blockers, but not alpha blockade and ACE inhibitors, produced a worsening of long-term glycemic control. Beta blockade was also associated with some detrimental effects on the lipid profile. These effects were most pronounced with propranolol. Using an alpha blocker together with the beta blocker prevented the worsening attributable to beta blockade 5.

Common questions

Can I take Acarbose and Carvedilol together?

Carvedilol can shift your blood sugar and hide the fast-heartbeat warning of a low, so monitor more closely and know the other low-sugar signs; your team can adjust doses as needed. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Acarbose and Carvedilol interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How quickly could this interaction happen?

The documented onset is "delayed". Effects tend to build up gradually over days to weeks.

How is the Acarbose and Carvedilol interaction managed?

This combination is commonly used and manageable. The main points: Keep taking both acarbose and carvedilol as prescribed unless your prescriber tells you otherwise. Your team may check your blood sugar more often, especially when starting or changing either drug. Your antidiabetic dose may need to be adjusted and individualized by your care team. Learn the non-heartbeat signs of low blood sugar (… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

From our Q&A

Real reader questions about these medications, each personally answered by our pharmacist:

Questions for your pharmacist

  • Does my dose of Acarbose or Carvedilol need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

References (7)

  1. Product Information: TOUJEO(R) subcutaneous injection, insulin glargine subcutaneous injection. sanofi-aventis (per manufacturer), Bridgewater, NJ, 2015. DailyMed
  2. Product Information: AMARYL(R) oral tablets, glimepiride oral tablets. Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2013. DailyMed
  3. Product Information: Glynase(R) PresTab(R) oral micronized tablets, glyburide oral micronized tablets. Pharmacia & Upjohn Co (per FDA), New York, NY, 2013. DailyMed
  4. Shorr RI, Ray WA, Daugherty JR, et al: Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. JAMA 1997; 278:40-43. DOI
  5. Whitcroft IA, Thomas JM, Rawsthorne A, et al: Effects of alpha and beta adrenoceptor blocking drugs and ACE inhibitors on long term glucose and lipid control in hypertensive non-insulin dependent diabetics. Horm Metab Res Suppl 1990; 22:42-46.
  6. Product Information: TENORMIN(R) oral tablets, atenolol oral tablets. AstraZeneca Pharmaceuticals LP (per FDA), Wilmington, DE, 2012. DailyMed
  7. Product Information: COREG CR(R) extended-release oral capsules, carvedilol phosphate extended-release oral capsules. GlaxoSmithKline, Research Triangle Park, NC, 2011. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.